CA Stock MarketDetailed Quotes

GUD Knight Therapeutics Inc

Watchlist
  • 5.690
  • 0.0000.00%
15min DelayMarket Closed Jul 5 16:00 ET
576.83MMarket Cap-35562P/E (TTM)

Knight Therapeutics Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
4.85%86.6M
11.80%328.2M
-9.13%74.2M
12.75%81.5M
18.58%89.91M
29.45%82.6M
20.57%293.56M
40.12%81.66M
-1.44%72.28M
15.23%75.82M
Operating revenue
4.85%86.6M
11.80%328.2M
-9.13%74.2M
12.75%81.5M
18.58%89.91M
29.45%82.6M
20.57%293.56M
40.12%81.66M
-1.44%72.28M
15.23%75.82M
Cost of revenue
7.34%44.91M
12.89%175.55M
-10.69%39.98M
-1.34%41.32M
39.67%52.41M
33.53%41.84M
21.42%155.5M
48.84%44.77M
17.73%41.88M
1.62%37.53M
Gross profit
2.30%41.7M
10.57%152.65M
-7.25%34.22M
32.17%40.18M
-2.09%37.49M
25.51%40.76M
19.62%138.06M
30.83%36.89M
-19.50%30.4M
32.64%38.3M
Operating expense
11.13%39.04M
-5.70%146.28M
-25.49%34.3M
-2.69%39.25M
4.57%37.6M
7.12%35.13M
20.96%155.12M
7.48%46.03M
19.53%40.34M
24.62%35.96M
Selling and administrative expenses
17.28%23.19M
-5.56%83.69M
-23.50%18.93M
-3.64%23M
2.33%21.99M
6.74%19.77M
19.16%88.62M
10.97%24.74M
27.30%23.87M
15.33%21.49M
-Selling and marketing expense
18.60%12.65M
-4.53%46.28M
-24.90%10.82M
-11.39%11.92M
17.83%12.87M
10.06%10.67M
24.04%48.47M
17.18%14.4M
34.69%13.46M
18.97%10.93M
-General and administrative expense
15.73%10.54M
-6.81%37.41M
-21.55%8.11M
6.37%11.08M
-13.69%9.12M
3.10%9.11M
13.75%40.15M
3.34%10.34M
18.86%10.42M
11.80%10.57M
Research and development costs
18.94%4.98M
18.94%17.55M
2.85%4.26M
12.99%4.77M
27.08%4.34M
40.36%4.19M
16.25%14.76M
18.42%4.14M
11.26%4.22M
31.99%3.41M
Depreciation amortization depletion
-2.68%10.87M
-12.95%45.04M
-35.21%11.12M
-6.23%11.48M
1.98%11.27M
-1.04%11.17M
25.66%51.74M
0.68%17.16M
9.32%12.24M
44.79%11.06M
-Depreciation and amortization
-2.68%10.87M
-12.95%45.04M
-35.21%11.12M
-6.23%11.48M
1.98%11.27M
-1.04%11.17M
25.66%51.74M
0.68%17.16M
9.32%12.24M
44.79%11.06M
Operating profit
-52.78%2.66M
137.34%6.37M
99.09%-83K
109.36%930K
-104.71%-110K
1,882.59%5.63M
-32.95%-17.06M
37.50%-9.15M
-347.05%-9.93M
14,500.00%2.34M
Net non-operating interest income (expenses)
-88.59%64K
-97.84%87K
-151.22%-1.01M
-54.02%452K
-88.31%83K
52.03%561K
7.12%4.03M
127.75%1.97M
121.90%983K
-36.49%710K
Non-operating interest income
-21.21%2.64M
18.28%12.58M
-27.73%3.08M
24.09%3.06M
27.19%3.09M
126.49%3.35M
44.03%10.63M
94.13%4.26M
75.61%2.46M
35.89%2.43M
Non-operating interest expense
-7.67%2.58M
89.21%12.49M
78.37%4.09M
76.00%2.6M
74.96%3M
151.22%2.79M
82.42%6.6M
72.28%2.29M
54.22%1.48M
157.04%1.72M
Other net income (expenses)
11.42%-9.87M
8.04%-28.45M
-57.03%-25.06M
-23.32%7.52M
109.92%239K
50.19%-11.14M
-296.29%-30.93M
-2,336.49%-15.96M
168.30%9.8M
-109.47%-2.41M
Gain on sale of security
-21.73%-14.33M
-91.86%-25.39M
-335.79%-16.89M
-20.52%4.25M
69.26%-979K
47.79%-11.77M
-187.03%-13.24M
704.30%7.16M
137.72%5.34M
-112.60%-3.19M
Special income (charges)
490.11%4.3M
72.58%-5.96M
57.66%-8.96M
197.50%1.36M
63.31%908K
162.82%728K
-5,235.22%-21.72M
-10,222.49%-21.16M
-1,620.65%-1.4M
205.49%556K
-Less:Impairment of capital assets
----
-61.39%9.26M
-57.72%9.26M
--0
----
----
--23.98M
--21.9M
--2.08M
----
-Less:Other special charges
-490.11%-4.3M
-46.02%-3.3M
59.49%-303K
-100.29%-1.36M
-63.31%-908K
-162.82%-728K
-434.75%-2.26M
-257.89%-748K
-640.22%-681K
-205.49%-556K
Other non-operating income (expenses)
279.79%169K
-27.83%2.91M
139.82%782K
-67.46%1.91M
41.55%310K
-4.44%-94K
3,044.53%4.03M
-711.84%-1.96M
2,148.95%5.86M
1,252.63%219K
Income before tax
-44.44%-7.14M
49.98%-21.99M
-13.04%-26.15M
945.59%8.9M
-66.67%212K
77.83%-4.95M
-757.10%-43.96M
-60.39%-23.14M
108.61%851K
-97.61%636K
Income tax
-157.48%-2.6M
63.37%-5.15M
77.02%-1.83M
6.76%-690K
13.40%-1.63M
71.18%-1.01M
-56.57%-14.07M
-29.79%-7.95M
43.16%-740K
22.60%-1.88M
Earnings from equity interest net of tax
Net income
-15.47%-4.55M
43.68%-16.84M
-60.17%-24.33M
502.64%9.59M
-26.87%1.84M
79.07%-3.94M
-290.70%-29.89M
-82.97%-15.19M
118.53%1.59M
-91.33%2.52M
Net income continuous operations
-15.47%-4.55M
43.68%-16.84M
-60.17%-24.33M
502.64%9.59M
-26.87%1.84M
79.07%-3.94M
-290.70%-29.89M
-82.97%-15.19M
118.53%1.59M
-91.33%2.52M
Noncontrolling interests
Net income attributable to the company
-15.47%-4.55M
43.68%-16.84M
-60.17%-24.33M
502.64%9.59M
-26.87%1.84M
79.07%-3.94M
-290.70%-29.89M
-82.97%-15.19M
118.53%1.59M
-91.33%2.52M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-15.47%-4.55M
43.68%-16.84M
-60.17%-24.33M
502.64%9.59M
-26.87%1.84M
79.07%-3.94M
-290.70%-29.89M
-82.97%-15.19M
118.53%1.59M
-91.33%2.52M
Diluted earnings per share
0.00%-0.04
38.46%-0.16
-76.92%-0.23
800.00%0.09
0.00%0.02
75.00%-0.04
-300.00%-0.26
-116.67%-0.13
114.29%0.01
-91.30%0.02
Basic earnings per share
0.00%-0.04
38.46%-0.16
-76.92%-0.23
800.00%0.09
0.00%0.02
75.00%-0.04
-300.00%-0.26
-116.67%-0.13
114.29%0.01
-91.30%0.02
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 4.85%86.6M11.80%328.2M-9.13%74.2M12.75%81.5M18.58%89.91M29.45%82.6M20.57%293.56M40.12%81.66M-1.44%72.28M15.23%75.82M
Operating revenue 4.85%86.6M11.80%328.2M-9.13%74.2M12.75%81.5M18.58%89.91M29.45%82.6M20.57%293.56M40.12%81.66M-1.44%72.28M15.23%75.82M
Cost of revenue 7.34%44.91M12.89%175.55M-10.69%39.98M-1.34%41.32M39.67%52.41M33.53%41.84M21.42%155.5M48.84%44.77M17.73%41.88M1.62%37.53M
Gross profit 2.30%41.7M10.57%152.65M-7.25%34.22M32.17%40.18M-2.09%37.49M25.51%40.76M19.62%138.06M30.83%36.89M-19.50%30.4M32.64%38.3M
Operating expense 11.13%39.04M-5.70%146.28M-25.49%34.3M-2.69%39.25M4.57%37.6M7.12%35.13M20.96%155.12M7.48%46.03M19.53%40.34M24.62%35.96M
Selling and administrative expenses 17.28%23.19M-5.56%83.69M-23.50%18.93M-3.64%23M2.33%21.99M6.74%19.77M19.16%88.62M10.97%24.74M27.30%23.87M15.33%21.49M
-Selling and marketing expense 18.60%12.65M-4.53%46.28M-24.90%10.82M-11.39%11.92M17.83%12.87M10.06%10.67M24.04%48.47M17.18%14.4M34.69%13.46M18.97%10.93M
-General and administrative expense 15.73%10.54M-6.81%37.41M-21.55%8.11M6.37%11.08M-13.69%9.12M3.10%9.11M13.75%40.15M3.34%10.34M18.86%10.42M11.80%10.57M
Research and development costs 18.94%4.98M18.94%17.55M2.85%4.26M12.99%4.77M27.08%4.34M40.36%4.19M16.25%14.76M18.42%4.14M11.26%4.22M31.99%3.41M
Depreciation amortization depletion -2.68%10.87M-12.95%45.04M-35.21%11.12M-6.23%11.48M1.98%11.27M-1.04%11.17M25.66%51.74M0.68%17.16M9.32%12.24M44.79%11.06M
-Depreciation and amortization -2.68%10.87M-12.95%45.04M-35.21%11.12M-6.23%11.48M1.98%11.27M-1.04%11.17M25.66%51.74M0.68%17.16M9.32%12.24M44.79%11.06M
Operating profit -52.78%2.66M137.34%6.37M99.09%-83K109.36%930K-104.71%-110K1,882.59%5.63M-32.95%-17.06M37.50%-9.15M-347.05%-9.93M14,500.00%2.34M
Net non-operating interest income (expenses) -88.59%64K-97.84%87K-151.22%-1.01M-54.02%452K-88.31%83K52.03%561K7.12%4.03M127.75%1.97M121.90%983K-36.49%710K
Non-operating interest income -21.21%2.64M18.28%12.58M-27.73%3.08M24.09%3.06M27.19%3.09M126.49%3.35M44.03%10.63M94.13%4.26M75.61%2.46M35.89%2.43M
Non-operating interest expense -7.67%2.58M89.21%12.49M78.37%4.09M76.00%2.6M74.96%3M151.22%2.79M82.42%6.6M72.28%2.29M54.22%1.48M157.04%1.72M
Other net income (expenses) 11.42%-9.87M8.04%-28.45M-57.03%-25.06M-23.32%7.52M109.92%239K50.19%-11.14M-296.29%-30.93M-2,336.49%-15.96M168.30%9.8M-109.47%-2.41M
Gain on sale of security -21.73%-14.33M-91.86%-25.39M-335.79%-16.89M-20.52%4.25M69.26%-979K47.79%-11.77M-187.03%-13.24M704.30%7.16M137.72%5.34M-112.60%-3.19M
Special income (charges) 490.11%4.3M72.58%-5.96M57.66%-8.96M197.50%1.36M63.31%908K162.82%728K-5,235.22%-21.72M-10,222.49%-21.16M-1,620.65%-1.4M205.49%556K
-Less:Impairment of capital assets -----61.39%9.26M-57.72%9.26M--0----------23.98M--21.9M--2.08M----
-Less:Other special charges -490.11%-4.3M-46.02%-3.3M59.49%-303K-100.29%-1.36M-63.31%-908K-162.82%-728K-434.75%-2.26M-257.89%-748K-640.22%-681K-205.49%-556K
Other non-operating income (expenses) 279.79%169K-27.83%2.91M139.82%782K-67.46%1.91M41.55%310K-4.44%-94K3,044.53%4.03M-711.84%-1.96M2,148.95%5.86M1,252.63%219K
Income before tax -44.44%-7.14M49.98%-21.99M-13.04%-26.15M945.59%8.9M-66.67%212K77.83%-4.95M-757.10%-43.96M-60.39%-23.14M108.61%851K-97.61%636K
Income tax -157.48%-2.6M63.37%-5.15M77.02%-1.83M6.76%-690K13.40%-1.63M71.18%-1.01M-56.57%-14.07M-29.79%-7.95M43.16%-740K22.60%-1.88M
Earnings from equity interest net of tax
Net income -15.47%-4.55M43.68%-16.84M-60.17%-24.33M502.64%9.59M-26.87%1.84M79.07%-3.94M-290.70%-29.89M-82.97%-15.19M118.53%1.59M-91.33%2.52M
Net income continuous operations -15.47%-4.55M43.68%-16.84M-60.17%-24.33M502.64%9.59M-26.87%1.84M79.07%-3.94M-290.70%-29.89M-82.97%-15.19M118.53%1.59M-91.33%2.52M
Noncontrolling interests
Net income attributable to the company -15.47%-4.55M43.68%-16.84M-60.17%-24.33M502.64%9.59M-26.87%1.84M79.07%-3.94M-290.70%-29.89M-82.97%-15.19M118.53%1.59M-91.33%2.52M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -15.47%-4.55M43.68%-16.84M-60.17%-24.33M502.64%9.59M-26.87%1.84M79.07%-3.94M-290.70%-29.89M-82.97%-15.19M118.53%1.59M-91.33%2.52M
Diluted earnings per share 0.00%-0.0438.46%-0.16-76.92%-0.23800.00%0.090.00%0.0275.00%-0.04-300.00%-0.26-116.67%-0.13114.29%0.01-91.30%0.02
Basic earnings per share 0.00%-0.0438.46%-0.16-76.92%-0.23800.00%0.090.00%0.0275.00%-0.04-300.00%-0.26-116.67%-0.13114.29%0.01-91.30%0.02
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
%Chg